Fludarabine, mitoxantrone and dexametasone in the treatment of relapsed and refractory low-grade non-Hodgkin lymphoma.

被引：0
|
作者：
Sawczuk-Chabin, J
Kalinka, E
Centkowski, P
Budziszewska, K
Ceglarek, B
Najda, J
Blasinska-Morawiec, M
Sulek, K
Holowiecki, J
Konopka, L
Warzocha, K
机构：
[1] Inst Hematol & Blood Transfus, Dept Hematol, Warsaw, Poland
[2] Reg Canc Ctr, Dept Proliferat Dis, Lodz, Poland
[3] Mil Inst Med, Dept Hematol, Warsaw, Poland
[4] Inst Hematol & Blood Transfus, Dept Hematol & Internal Med, Warsaw, Poland
[5] L Warynski Silesian Med Acad, Dept Hematol, Katowice, Poland
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.4738.4738
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4738
引用
收藏
页码：265B / 265B
页数：1
相关论文
共 50 条
  • [21] Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
    Gordon, LI
    Witzig, TE
    Wiseman, GA
    Flinn, IW
    Spies, SS
    Silverman, DH
    Emmanuolides, C
    Cripe, L
    Saleh, M
    Czuczman, MS
    Olejnik, T
    White, CA
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 87 - 92
  • [22] Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphoma
    Schmitt, Michael
    Trenschel, Rudolf
    Sayer, Herbert G.
    Schneider, Catarina
    Glass, Aenne
    Hilgendorf, Inken
    Treschl, Anne
    Junghanss, Christian
    Borchert, Kersten
    Koenigsmann, Michael
    Casper, Jochen
    Beelen, Dietrich W.
    Freund, Mathias
    Kahl, Christoph
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (05) : 773 - 782
  • [23] Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma
    Tulpule, A
    Schiller, G
    Harvey-Buchanan, LA
    Lee, M
    Espina, BM
    Khan, AU
    Boswell, W
    Nathwani, B
    Levine, AM
    CANCER, 1998, 83 (11) : 2370 - 2376
  • [24] Autologous hemopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
    Tamaki, K
    Lee, CK
    deMagalhaes-Silverman, M
    Hohl, RJ
    Joyce, JK
    Gingrich, RD
    BLOOD, 1998, 92 (10) : 459A - 459A
  • [25] Cladribine in the treatment of low-grade non-Hodgkin's lymphoma
    Piro, LD
    SEMINARS IN HEMATOLOGY, 1996, 33 (01) : 34 - 39
  • [26] Vaccine strategies in the treatment of low-grade non-Hodgkin lymphoma
    Koumarianou, Anna
    Kountourakis, Pantelis
    Economopoulos, Theophanis
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2008, 109 (3-5): : 230 - 232
  • [27] Autologous blood or bone marrow transplantation for relapsed and partially responding low-grade non-Hodgkin's lymphoma.
    Mijovic, A
    Parker, J
    Salisbury, J
    Pagliuca, A
    Mufti, GJ
    CANCER RESEARCH THERAPY & CONTROL, 1998, 5 (04): : 253 - 260
  • [28] Bendamustine, methotrexate, mitoxantrone, and prednisolone (BMMP) for the treatment of relapsed or refractory high-grade non-Hodgkin's lymphoma
    Kahl, C
    Herold, M
    Hoffkes, HG
    Franke, A
    ONKOLOGIE, 1997, 20 (05): : 406 - 408
  • [29] Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: A phase II study of the Hellenic Cooperative Oncology Group
    Dimopoulos, MA
    Fountzilas, G
    Papageorgiou, E
    Kiamouris, C
    Mantzios, G
    Anagnostopoulos, A
    Nicolaides, C
    Economopoulos, T
    LEUKEMIA & LYMPHOMA, 2002, 43 (01) : 111 - 114
  • [30] Fludarabine-induced tumour lysis in low-grade non-Hodgkin's lymphoma
    Killick, S
    Mercieca, J
    Nandi, A
    Behrens, J
    CLINICAL AND LABORATORY HAEMATOLOGY, 1997, 19 (01): : 79 - 80
12345